Annette M Lim

7PUBLICATIONS
14CO-AUTHORS
Immunogenetics (incl. genetic immunology)Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsHaematological tumoursPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Oct 15, 2025
Consensus-based disease definitions for endocrine immune-related adverse events of immune checkpoint inhibitors.

Ling Zhu, Yee-Ming M Cheung, Cherie Chiang

|Oct 11, 2025
A two-phase study investigating the quality of life benefit of additional 0.5% cocaine mouthwash to institutional standard of care mucositis management in head and neck cancer patients undergoing radiotherapy or chemoradiotherapy.

Piyush Grover, Colin Tang, Angela Jacques

|Aug 27, 2025
Impact of Adjuvant Cemiplimab in High-Risk Cutaneous Squamous Cell Carcinoma.

Annette M Lim, Sandro Porceddu, Danny Rischin

|Apr 27, 2024
A Retrospective Review and Comprehensive Tumour Profiling of Advanced Non-Melanomatous Cutaneous Spindle Cell Neoplasms Treated with Immune-Checkpoint Inhibitors.

Luke S McLean, Annette M Lim, Christopher Angel

|Nov 27, 2021
Biology and Treatment Advances in Cutaneous Squamous Cell Carcinoma.

Alesha A Thai, Annette M Lim, Benjamin J Solomon

|Nov 20, 2021
Clinicopathological characteristics and clinical morbidity in high-risk head and neck cutaneous squamous cell carcinoma patients in Western Australia.

Piyush Grover, Stephanie Flukes, Angela Jacques

Pageof 2

Frequent Collaborators

2 joint publications

Piyush Grover

2 joint publications

Danny Rischin

1 joint publications

Stephanie Flukes

1 joint publications

Angela Jacques